Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

699

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

699 results for “TB”

Learn how ShareScore rates datasets ↗
dryad36/100

Determinants of QuantiFERON Plus-diagnosed tuberculosis infection in adult Ugandan TB contacts: A cross-sectional study

<p>Background</p> <p>The tuberculin skin test is commonly used to diagnose latent tuberculosis infection (LTBI) in resource-limited settings, but its specificity is limited by factors including cross-reactivity with BCG vaccine and environmental mycobacteria. Interferon-gamma release assays (IGRA) overcome this problem by detecting <em>M</em>. <em>tuberculosis</em> complex-specific responses, but studies to determine risk factors for IGRA-positivity in high TB burden settings are lacking.</p> <p>Methods</p> <p>We conducted a cross-sectional study to determine factors associated with a positive IGRA by employing the QuantiFERON-TB® Gold-plus (QFT Plus) assay in a cohort of asymptomatic adult TB contacts in Kampala, Uganda. Multivariate logistic regression analysis with forward stepwise logit function was employed to identify independent correlates of QFT Plus-positivity.</p> <p>Results</p> <p>Of the 202 participants enrolled, 129/202 (64%) were female, 173/202 (86%) had a BCG scar, and 67/202 (33%) were HIV-infected. Overall, 105/192 (54%, 95% CI 0.48–0.62) participants had a positive QFT Plus result. Increased risk of QFT-Plus positivity was independently associated with manual employment/unemployment vs. professional employment (adjusted odds ratio (aOR) 2.18, 95% CI 1.01–4.72), a family vs. non-family relation to the index patient (aOR 2.87, 95% CI 1.33–6.18), living in the same vs. a different house as the index (aOR 3.05, 95% CI 1.28–7.29), a higher body mass index (BMI) (aOR per additional kg/m2 1.09, 95% CI 1.00–1.18) and tobacco smoking vs. not (aOR 2.94, 95% CI 1.00–8.60). HIV infection was not associated with QFT-Plus positivity (aOR 0.91, 95% CI 0.42–1.96).</p> <p>Conclusion</p> <p>The prevalence of IGRA positivity in this study population was lower than previously estimated. Tobacco smoking and raised BMI are hitherto unappreciated determinants of LTBI risk in this setting.</p>

opencc-zeroOct 2022View details →
zenodo36/100

TB-CARE: A Novel Convolutional Autoencoder-based Tuberculosis Classification System with Enhanced EfficientNet

<p><span>The novel framework for TB classification using Convolutional AutoencodeR with EfficientNet (TB-CARE) involves the utilization of a convolutional autoencoder for feature extraction, an affinity propagation clustering method for selecting templates, and an enhanced EfficientNet (EEffNet) for classification. Extensive tests are performed on datasets that are freely accessible. The results of our methodology surpassed those of previous approaches, demonstrating its practicality for real-world applications. By leveraging deep learning models within the ensemble method, TB classification achieves a notable area under the receiver operating characteristic of up to 0.99, outperforming other tested classifiers and setting a new benchmark. EEffNet exhibits outstanding performance with an accuracy of 99.8%, sensitivity of 99.8%, and specificity of 99.7% on the NIH chest X-ray dataset and accuracy of 99.6%, sensitivity of 99.9%, and specificity of 99.4% on TBX11 k Dataset. These results indicate that employing features extracted from various image sources can significantly enhance the detection rate.</span></p>

opencc-by-4.0Jul 2024View details →
zenodo36/100

Fluctuation electron microscopy data from amorphous Tb-Co and SiNx

<p>These datasets were used for fluctuation electron microscopy (FEM) analysis of&nbsp;amorphous Tb<sub>17</sub>Co<sub>83</sub>.&nbsp;The Tb<sub>17</sub>Co<sub>83</sub> is 30&nbsp;nm thick. The deposited Ta is sandwiched between two layers of amorphous 10 nm-thick SiN<sub>x</sub>. Data are&nbsp;also provided for SiN<sub>x</sub>&nbsp;deposited on&nbsp;SiN<sub>x</sub>. Samples include: (1)&nbsp;Tb<sub>17</sub>Co<sub>83&nbsp;</sub>deposited at 20<sup>o</sup>C, (2)&nbsp;Tb<sub>17</sub>Co<sub>83&nbsp;</sub>deposited at 200<sup>o</sup>C, (3)&nbsp;Tb<sub>17</sub>Co<sub>83&nbsp;</sub>deposited at 300<sup>o</sup>C, (4)&nbsp;Tb<sub>17</sub>Co<sub>83&nbsp;</sub>deposited at 20<sup>o</sup>C and annealed at&nbsp;200<sup>o</sup>C, and (5)&nbsp;Tb<sub>17</sub>Co<sub>83&nbsp;</sub>deposited at 20<sup>o</sup>C and annealed at 300<sup>o</sup>C.</p> <p>FEM patterns were collected in a FEI TitanX operated at 200 kV with a convergence angle of 0.51 mrad and a camera length of 300 mm.&nbsp;</p> <p>Samples (1) Tb<sub>17</sub>Co<sub>83&nbsp;</sub>deposited at 20<sup>o</sup>C and (3)&nbsp;Tb<sub>17</sub>Co<sub>83&nbsp;</sub>deposited at 300<sup>o</sup>C&nbsp;were tilted between 0<sup>o</sup>&nbsp;and 40<sup>o</sup>&nbsp;in 5<sup>o</sup>&nbsp;increments. The tilted FEM data is also included.</p> <p><strong>File types</strong></p> <p>.dm4 (Gatan DigitalMicrograph) files are provided with the raw scanning nanodiffraction data for each sample. Each sample has multiple associated .dm4 files because measurements were repeated for statistical purposes.</p> <p><strong>Data processing</strong></p> <p>For the steps involved in FEM data processing, please visit:&nbsp;https://github.com/ScottLabUCB/FEM</p> <p><strong>File name format</strong></p> <p>Using &quot;gRTa200_t00_200kV_cl300_ca0p51_exp0p3_spot9_ss5nm_04.dm4&quot; as an example, the naming format is:</p> <p>&quot;sample descriptor _ tilt angle _ TEM voltage_camera length [mm] _ convergence angle&nbsp;[mrad] _exposure [sec] _spot size _ step size between probe positions [nm]_ data set number.dm4&quot;</p> <p>Data are from Tb<sub>17</sub>Co<sub>83&nbsp;</sub>capped with SiN<sub>x</sub> unless only &quot;SiN&quot; is stated in the descriptor, in which case the data are from SiN<sub>x</sub>.</p> <p>For the tilted data, the naming format is:</p> <p>&quot;sample descriptor&nbsp;_ tilt angle _ spot size _ exposure [sec]&nbsp; convergence angle [mrad]_ bin factor _camera length _ TEM voltage _ data set number.dm4&quot;</p> <p>For all data, the step size is 5 nm, the spot size is 9, the exposure is 0.3 seconds, the convergence angle is 0.51 mrad, the camera length in 300 mm, and the TEM extraction voltage is 200 kV.</p> <p>&nbsp;</p>

opencc-by-4.0Jun 2023View details →
ClinicalTrials.gov36/100

A Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary TB

ClinicalTrials.gov study NCT02414828. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Shorter and Safer Treatment Regimens for Latent TB

ClinicalTrials.gov study NCT06498414. IPD Sharing: YES. Countries: 5. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

ClinicalTrials.gov study NCT00685360. IPD Sharing: YES. Countries: 9. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Treatment Shortening of MDR-TB Using Existing and New Drugs

ClinicalTrials.gov study NCT02619994. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden

ClinicalTrials.gov study NCT03315962. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease

ClinicalTrials.gov study NCT01424501. IPD Sharing: YES. Countries: 2. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Clinical Risk Score for Early Management of TB in Uganda

ClinicalTrials.gov study NCT05122624. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).

ClinicalTrials.gov study NCT00449644. IPD Sharing: Not stated. Countries: 8. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)

ClinicalTrials.gov study NCT01936831. IPD Sharing: Not stated. Countries: 2. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB

ClinicalTrials.gov study NCT01751568. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Trial of High-Dose Rifampin in Patients With TB

ClinicalTrials.gov study NCT01408914. IPD Sharing: Not stated. Countries: 3. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents

ClinicalTrials.gov study NCT02075203. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

ClinicalTrials.gov study NCT04930744. IPD Sharing: YES. Countries: 1. Publications: 36.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment

ClinicalTrials.gov study NCT01380080. IPD Sharing: Not stated. Countries: 10. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

ClinicalTrials.gov study NCT01404312. IPD Sharing: Not stated. Countries: 10. Publications: 7.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB

ClinicalTrials.gov study NCT01918397. IPD Sharing: NO. Countries: 2. Publications: 5.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)

ClinicalTrials.gov study NCT01498419. IPD Sharing: Not stated. Countries: 2. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record